Department Researches & Publications

Faculty of Pharmacy

Assiut University

Department of Pharmaceutics

Research

Our research plan for the next 5 years (2019-2023):

Main research activities

Several active research groups in the department are engaged with different aspects of pharmaceutics. The research is directed towards high quality innovative topics aiming to publish applied articles.

The research plan in the period from 2019 till 2023 is still focusing on three distinct areas:

  1. Nanotechnology as a promising area of pharmaceutical science is a target for formulation of many drugs.
  2. Preformulation studies to improve the characteristics of drugs and/or dosage forms and development of more acceptable dosage forms.
  3. Targeted drug delivery systems

 

 

# Title Research Year
61 Liposomal and Ethosomal Gels for the Topical Delivery of Anthralin: Preparation, Comparative Evaluation and Clinical Assessment in Psoriatic Patients 2020
62 Latanoprost niosomes as a sustained release ocular delivery system for the
management of glaucoma 		2020
63 Nanomedicine Fight against Antibacterial Resistance: An Overview of the Recent Pharmaceutical Innovations 2020
64 Latanoprost niosomes as a sustained release ocular delivery system for the
management of glaucoma 		2020
65 Gene Therapy as an Innovative Approach to Sensitize Hepatocellular Carcinoma to Chemotherapy 2019
66 A Self-Nanoemulsifying Drug Delivery System for Enhancing the Oral Bioavailability of Candesartan Cilexetil: Ex Vivo and In Vivo Evaluation 2019
67 A Self-Nanoemulsifying Drug Delivery System for Enhancing the Oral Bioavailability of Candesartan Cilexetil: Ex Vivo and In Vivo Evaluation 2019
68 Development of Bi-Polymer Lipid Hybrid Nanocarrier (BLN) to Improve the Entrapment and Stability of Insulin for Efficient Oral Delivery 2019
69 Miniaturized Preparation of polymeric nanoparticles using droplet manipulation on open surfaces
DOI:10.1049/mnl.2019.0421 		2019
70 A Self-Nanoemulsifying Drug Delivery System for Enhancing the Oral Bioavailability of Candesartan Cilexetil: Ex Vivo and In Vivo Evaluation 2019